ResearcherUniversity of North TexasNo recent work listed
Umesh T. Sankpal
Matched on ORCID iD 0000-0001-6696-2315; OpenAlex author ID A5041786738. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper
Papers 6
- Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells. Co-author DOI 10.1016/j.procbio.2019.10.022↗
- Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. First author DOI 10.1016/j.critrevonc.2018.03.016↗
- Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors. First author DOI 10.1159/000495715↗
- Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.14651↗
- Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disruptin… Co-author DOI 10.1016/j.jnutbio.2016.01.003↗
- Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy. Co-author DOI 10.2174/092986712801661077↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Riyaz M. Basha · 6 shared papers, 2012–2020 · strength 0.44
- Paper Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic a… DOI 10.1016/j.procbio.2019.10.022↗
- Paper Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. DOI 10.1016/j.critrevonc.2018.03.016↗
- Paper Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. DOI 10.18632/oncotarget.14651↗
- Myrna Hurtado · 4 shared papers, 2017–2020 · strength 0.35
- Paper Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic a… DOI 10.1016/j.procbio.2019.10.022↗
- Paper Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. DOI 10.1016/j.critrevonc.2018.03.016↗
- Paper Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells. DOI 10.18632/oncotarget.14651↗
- Ganji Purnachandra Nagaraju · 2 shared papers, 2016–2018 · strength 0.14
- Paper Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. DOI 10.1016/j.critrevonc.2018.03.016↗
- Paper Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic can… DOI 10.1016/j.jnutbio.2016.01.003↗
- Bassel F. El‐Rayes · 2 shared papers, 2016–2018 · strength 0.14
- Paper Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer. DOI 10.1016/j.critrevonc.2018.03.016↗
- Paper Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic can… DOI 10.1016/j.jnutbio.2016.01.003↗
- Amalendu Prakash Ranjan · 1 shared paper, 2018 · strength 0.09
- Mamoru Shoji · 1 shared paper, 2016 · strength 0.05
- Omar Roger Kayaleh · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.